Infectious Disorders of the Lung Parenchyma. Matthew L. Paden, MD Pediatric Critical Care Fellow Emory University Children’s Healthcare of Atlanta at Egleston. Objectives. Worldwide epidemiology of the problem Review common etiologies Discuss empirical and disease specific treatment.
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
Matthew L. Paden, MD
Pediatric Critical Care Fellow
Children’s Healthcare of Atlanta at Egleston
Geographically-based evaluation of multi-drug resistance trends among Streptococcus pneumoniae in the USA: findings of the FAST surveillance initiative (2003-2004). Int J Antimicrob Agents. 2006 Dec;28(6):525-31.
Percent of organisms tested that have intermediate or resistant sensitivity patterns
* Not adjusted for inducible resistance
So which to choose?
dyspnea 83%; coryza 88%; fever 52-92%)
Rex, 1994; Phillips 1997; Nguyen, 1995; Anaissie, 1998
Flucon Itra AmB 5-FC
C. albicans S S S S
C. parapsilosis S S S S
C. tropicalisS S S S
C. glabrata SDD-R SDD-R IS
C. krusei RSDD-R I-r I-R
C. lusitaniae S S-SDDR R